Microscale culture of human liver cells for drug development

被引:929
作者
Khetani, Salman R. [1 ]
Bhatia, Sangeeta N. [1 ,2 ]
机构
[1] MIT, Dept Elect Engn & Comp Sci, Div Hlth Sci & Technol, Cambridge, MA 02139 USA
[2] Brigham & Womens Hosp, Div Med, Boston, MA 02115 USA
基金
美国国家科学基金会;
关键词
D O I
10.1038/nbt1361
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Tissue function depends on hierarchical structures extending from single cells (similar to 10 mu m) to functional subunits (100 mu m - 1 mm) that coordinate organ functions. Conventional cell culture disperses tissues into single cells while neglecting higher-order processes. The application of semiconductor-driven microtechnology in the biomedical arena now allows fabrication of microscale tissue subunits that may be functionally improved(1) and have the advantages of miniaturization(2). Here we present a miniaturized, multiwell culture system for human liver cells with optimized microscale architecture that maintains phenotypic functions for several weeks. The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicity(3). We demonstrate utility through assessment of gene expression profiles, phase I/II metabolism, canalicular transport, secretion of liver-specific products and susceptibility to hepatotoxins. The combination of microtechnology and tissue engineering may enable development of integrated tissue models in the so-called 'human on a chip'.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 30 条
[1]   Advances in bioartificial liver devices [J].
Allen, JW ;
Hassanein, T ;
Bhatia, SN .
HEPATOLOGY, 2001, 34 (03) :447-455
[2]   Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells [J].
Bhatia, SN ;
Balis, UJ ;
Yarmush, ML ;
Toner, M .
FASEB JOURNAL, 1999, 13 (14) :1883-1900
[3]   Geometric control of cell life and death [J].
Chen, CS ;
Mrksich, M ;
Huang, S ;
Whitesides, GM ;
Ingber, DE .
SCIENCE, 1997, 276 (5317) :1425-1428
[4]   The coculture: A system for studying the regulation of liver differentiation/proliferation activity and its control [J].
Corlu, A ;
Ilyin, G ;
Cariou, S ;
Lamy, I ;
Loyer, P ;
GuguenGuillouzo, C .
CELL BIOLOGY AND TOXICOLOGY, 1997, 13 (4-5) :235-242
[5]   Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes [J].
Donato, MT ;
Jiménez, N ;
Castell, JV ;
Gómez-Lechón, MJ .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (07) :699-706
[6]   Microstructured scaffolds for liver tissue cultures of high cell density:: Morphological and biochemical characterization of tissue aggregates [J].
Eschbach, E ;
Chatterjee, SS ;
Nöldner, M ;
Gottwald, E ;
Dertinger, H ;
Weibezahn, KF ;
Knedlitschek, G .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 95 (02) :243-255
[7]   New hepatocyte in vitro systems for drug metabolism:: Metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures [J].
Gebhardt, R ;
Hengstler, JG ;
Müller, D ;
Glöckner, R ;
Buenning, P ;
Laube, B ;
Schmelzer, E ;
Ullrich, M ;
Utesch, D ;
Hewitt, N ;
Ringel, M ;
Hilz, BR ;
Bader, A ;
Langsch, A ;
Koose, T ;
Burger, HJ ;
Maas, J ;
Oesch, F .
DRUG METABOLISM REVIEWS, 2003, 35 (2-3) :145-213
[8]   Liver cell models in in vitro toxicology [J].
Guillouzo, A .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1998, 106 :511-532
[9]   Primary hepatocytes:: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies [J].
Hewitt, Nicola J. ;
Lechon, Maria Jose Gomez ;
Houston, J. Brian ;
Hallifax, David ;
Brown, Hayley S. ;
Maurel, Patrick ;
Kenna, J. Gerald ;
Gustavsson, Lena ;
Lohmann, Christina ;
Skonberg, Christian ;
Guillouzo, Andre ;
Tuschl, Gregor ;
Li, Albert P. ;
LeCluyse, Edward ;
Groothuis, Geny M. M. ;
Hengstler, Jan G. .
DRUG METABOLISM REVIEWS, 2007, 39 (01) :159-234
[10]  
Isley William L, 2003, Expert Opin Drug Saf, V2, P581, DOI 10.1517/eods.2.6.581.21823